InvestSMART

Amplia Therapeutics Limited (ASX: ATX) - Announcements

Current share price for ATX : $0.145 0.01 (7.41%)+

ASX company news and announcements for Amplia Therapeutics Limited (ATX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Amplia Therapeutics Limited (ATX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Amplia Therapeutics Limited (ATX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Amplia Therapeutics Limited (ATX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$74 Notification regarding unquoted securities - ATX 1 Sep 2025 5:15PM $0.165 $0.145 fallen by 12.12%
$74 Notification regarding unquoted securities - ATX 1 Sep 2025 5:06PM $0.165 $0.145 fallen by 12.12%
$74 Notice under Section 708A(5)(e) of the Corporations Act 1 Sep 2025 9:49AM $0.165 $0.145 fallen by 12.12%
$74 Application for quotation of securities - ATX 1 Sep 2025 9:39AM $0.165 $0.145 fallen by 12.12%
$74 Application for quotation of securities - ATX 1 Sep 2025 9:35AM $0.165 $0.145 fallen by 12.12%
$74 AUSTRALIAN TRIAL SITES OPEN FOR NEW NARMAFOTINIB TRIAL 29 Aug 2025 8:24AM $0.170 $0.145 fallen by 14.71%
$74 Application for quotation of securities - ATX 29 Aug 2025 8:16AM $0.170 $0.145 fallen by 14.71%
$74 Results of Annual General Meeting 27 Aug 2025 11:58AM $0.175 $0.145 fallen by 17.14%
$74 Managing Director's Presentation to AGM 27 Aug 2025 10:08AM $0.185 $0.145 fallen by 21.62%
$74 Amplia Share Purchase Plan Raises $2.65 Million 26 Aug 2025 9:12AM $0.190 $0.145 fallen by 23.68%
$74 Presentation - Targeting Pancreatic Cancer and Beyond 7 Aug 2025 9:34AM $0.175 $0.145 fallen by 17.14%
$74 Positive ACCENT Trial Topline Data Released 6 Aug 2025 8:29AM $0.240 $0.145 fallen by 39.58%
$74 Share Purchase Plan Prospectus 1 Aug 2025 9:43AM $0.240 $0.145 fallen by 39.58%
$74 Change of Registered Office and Principal Place of Business 1 Aug 2025 8:20AM $0.240 $0.145 fallen by 39.58%
$74 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2025 8:45AM $0.240 $0.145 fallen by 39.58%
$74 Ceasing to be a substantial holder - Blueflag Holdings 30 Jul 2025 4:27PM $0.240 $0.145 fallen by 39.58%
$74 Change in substantial holding 30 Jul 2025 3:53PM $0.235 $0.145 fallen by 38.30%
$74 Change in substantial holding 30 Jul 2025 12:51PM $0.235 $0.145 fallen by 38.30%
$74 Australian Ethics Clearance for Pancreatic Cancer Trial 30 Jul 2025 8:43AM $0.235 $0.145 fallen by 38.30%
$74 Notice under Section 708A(5)(e) of the Corporations Act 29 Jul 2025 9:55AM $0.240 $0.145 fallen by 39.58%
$74 Application for quotation of securities - ATX 29 Jul 2025 9:50AM $0.240 $0.145 fallen by 39.58%
$74 Notice of Annual General Meeting/Proxy Form 25 Jul 2025 2:46PM $0.245 $0.145 fallen by 40.82%
$74 Notice under Section 708A(5)(e) of the Corporations Act 23 Jul 2025 4:11PM $0.270 $0.145 fallen by 46.30%
$74 Application for quotation of securities - ATX 23 Jul 2025 4:06PM $0.270 $0.145 fallen by 46.30%
$74 Capital Raising Presentation 23 Jul 2025 9:54AM $0.285 $0.145 fallen by 49.12%

51 - 75 of 530 results

Page 3 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.